A joint EU declaration makes culture's effect on health an official policy principle

A prescription implies four things: an indication, a dose, a comparator and an endpoint. The Montreal scheme, launched in 2018 by the art historian Nathalie Bondil, then director of the Montreal Museum of Fine Arts, with French-speaking Canadian doctors, defines only the first, and loosely ^[15]. A partner doctor can recommend that a patient visit the museum when the doctor anticipates it would benefit the patient's health ^[16]. The referring physician's expectation selects who attends, so any comparison drawn later between attenders and non-attenders carries that selection inside it.

The causal claim underneath all of this predates the declaration. The health ecosystem idea was first put forward in a 2019 WHO report asking what the real benefits of engaging in the arts for health and well-being are ^[10]. According to that report, artistic activities engage aesthetic appreciation, imagination, sensory stimulation, emotional response and cognitive stimulation at the same time, and trigger psychological, physiological, social and behavioural responses that benefit health ^[11]. Five channels at once is a plausible reason for an effect to exist without identifying which of the five carries it.

The delivery record is long. MoMA was one of the first museums to formalise, with help from health care professionals, a programme for a clinically defined audience, people living with Alzheimer's disease ^[12], and the tours aim to give people in the early and intermediate stages of the disease a space for expression and exchange, drawing on iconic works of modern art ^[14]. Twenty years of monthly tours comes to roughly 240 sessions by 2026 ^[1], and the programme had been running twelve years before the first museum prescription was written in Montreal ^[2]. The account says nothing about effect size, comparison group or trial design for either programme ^[3].

Culture Next's report contains the field's hardest design problem. It describes culture not as a substitute for social, health or educational policy but as fostering care through participation itself, through the meeting places and cultural spaces that cultural life makes possible ^[7]. If participation is the active ingredient, a museum visit measured against nothing measures company as much as art. Separating the two needs a comparator: another group activity, same duration, same number of people in the room.

The same report asks cities to move past an access approach, the one that brings young people to institutions, and to recognise the role they already play as creators and organisers outside institutional frameworks, a position it ties to the right to culture ^[8]. The right-to-culture framing removes the endpoint question.

The neuroscience priority sits awkwardly against the outcomes the Commission has named. The phys.org account describes the shift as placing a new priority on neuroscience research into how cultural practices affect the brain and well-being ^[5], while the Commission's 2025 report "Culture and Health-Time to Act" frames the problem as post-pandemic burnout, an ageing population, increasing social isolation, a worrying geopolitical context and growing inequalities ^[9]. Those are counted in attendance logs, loneliness scales and service use. In my view the brain work will end up explaining an effect that the population measures have to establish first.